A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Psoriatic Arthritis
Related studies linked through entity extraction aliases.
A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting Ustekinumab
- Status
- COMPLETED
- Phase
- N/A
An Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis.
- Status
- TERMINATED
- Phase
- PHASE2
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases
- Status
- COMPLETED
- Phase
- NA
Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons
- Status
- RECRUITING
- Phase
- N/A
Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service
- Status
- COMPLETED
- Phase
- N/A
Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases
- Status
- RECRUITING
- Phase
- N/A
Pharmacist CVD Intervention for Patients With Inflammatory Arthritis
- Status
- UNKNOWN
- Phase
- NA
A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE4
Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA
- Status
- COMPLETED
- Phase
- PHASE3
Remission and Flare in Psoriatic Arthritis: a Prospective 6-month Study With a Double Perspective.
- Status
- COMPLETED
- Phase
- N/A
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)
- Status
- COMPLETED
- Phase
- PHASE3
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess Efficacy and Safety of Filgotinib in Active Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
The Norwegian Drug Monitoring Study
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety of Fecal Microbiota Transplantation in Peripheral Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- NA
DC-STAMP: Regulators of Osteoclastogenesis and Response Marker in PsA
- Status
- COMPLETED
- Phase
- N/A
Interval Training Study in Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- NA
A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation
- Status
- COMPLETED
- Phase
- N/A
A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002 (NCT02719171)
- Status
- COMPLETED
- Phase
- PHASE2